Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 08, 2023
TLRY Bullish Market Trend: RSI Oscillator Predicts 80% Upward Shift

TLRY Bullish Market Trend: RSI Oscillator Predicts 80% Upward Shift

Market Neutral Strategy (TA&FA) with TLRY: A Statistical Perspective on the Bullish Trend

The Trading Analysis (TA) and Fundamental Analysis (FA) insights into Tilray, Inc. (TLRY) reveal an increasingly positive outlook. The technical indicators, including the RSI Oscillator, Stochastic Oscillator, and MACD, along with the recent price performance, all point towards a strong likelihood of continued price appreciation.

The Relative Strength Index (RSI) - a momentum oscillator that measures the speed and change of price movements - for TLRY indicates a shifting trend from downward to upward. Out of 45 instances where TLRY's RSI Indicator exited the oversold territory, 36 resulted in a price increase. This translates to an 80% probability of the stock price continuing its upward trend, as suggested by Tickeron's analysis.

Meanwhile, the Stochastic Oscillator - another momentum indicator comparing a particular closing price of a security to a range of its prices over a certain period of time - reinforces the RSI's upward trend prediction for TLRY. After exiting the oversold zone, the Stochastic Oscillator has historically led to an increase in TLRY's price in 53 out of 66 cases, implying an 80% probability of a continued upward trend.

The Moving Average Convergence Divergence (MACD) for TLRY, which is used to identify possible buy and sell signals, turned positive on June 21, 2023. This is a bullish signal that suggests upward price momentum. Historical data shows that when TLRY's MACD turned positive, the stock continued its rise in 36 out of 47 instances over the subsequent month. This suggests a 77% likelihood of TLRY maintaining its upward trajectory.

In addition, the recent +5.26% 3-day advance for TLRY offers a further hint at the stock's potential for more gains. History shows that in 179 of 220 situations where TLRY advanced for three consecutive days, the price climbed even further within the following month. This statistical occurrence suggests an 81% chance of a continued upward trend.

These insights project an optimistic future for TLRY. The combination of RSI, Stochastic Oscillator, and MACD analyses along with the recent price movements put TLRY in a promising light for those considering a market-neutral strategy. This TA&FA approach for TLRY has yielded a commendable 12.29% return, showcasing the potential of this strategy in choppy market conditions and reinforcing the advantage of employing multiple technical indicators to predict market trends.

Related Ticker: TLRY

TLRY in -3.17% downward trend, sliding for three consecutive days on June 25, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where TLRY declined for three days, in of 354 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TLRY as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Aroon Indicator for TLRY entered a downward trend on July 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TLRY's RSI Indicator exited the oversold zone, of 47 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where TLRY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TLRY just turned positive on July 02, 2026. Looking at past instances where TLRY's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TLRY advanced for three days, in of 204 cases, the price rose further within the following month. The odds of a continued upward trend are .

TLRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.356) is normal, around the industry mean (79.618). P/E Ratio (0.000) is within average values for comparable stocks, (97.708). TLRY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.629). Dividend Yield (0.000) settles around the average of (0.035) among similar stocks. P/S Ratio (0.571) is also within normal values, averaging (95.237).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TLRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are Teva Pharmaceutical Industries Limited (NYSE:TEVA), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Bausch Health Companies (NYSE:BHC), Tilray Brands Inc. (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Journey Medical Corp (NASDAQ:DERM), Aurora Cannabis (NASDAQ:ACB).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.13B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 1%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 19%. ADCT experienced the highest price growth at 26%, while BTAI experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was -28% and the average quarterly volume growth was -25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 49
P/E Growth Rating: 66
Price Growth Rating: 55
SMR Rating: 87
Profit Risk Rating: 82
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
TLRY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a holding company, whose subsidiaries engages in research, cultivation, processing and distribution of medical cannabis

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Biotechnology
Address
265 Talbot Street West
Phone
+1 844 845-7291
Employees
1600
Web
https://www.tilray.com
Interact to see
Advertisement
TSM shares have remained relatively resilient despite heightened volatility, supported by the ongoing global buildout of AI infrastructure. Investor attention has centered on capacity expansion updates and signals from major customers, particularly in high-performance computing. While execution risks remain in the near term, leadership in advanced manufacturing and packaging continues to anchor TSM’s long-term growth narrative, even as global supply chains face scrutiny.
Rivian (RIVN) is carving out a distinct position in the electric vehicle market by targeting adventure-focused consumers, commercial fleets, and long-term sustainable transportation solutions. As the EV industry moves beyond early adoption toward scalability and efficiency, Rivian is emphasizing broader product offerings, streamlined manufacturing, and software-enabled services.
Aon plc (AON) reported third-quarter 2025 revenue of $3.997 billion, representing a 7% year-over-year increase with equal organic growth. Adjusted earnings per share came in at $3.05, exceeding expectations. In late November, Moody’s reaffirmed Aon’s Baa2 credit rating and revised the outlook to positive, citing reduced leverage following the NFP acquisition.
General Motors (GM) is in the midst of a long-term transformation, evolving from a traditional automotive manufacturer into a technology-focused mobility company. By combining its global scale, manufacturing capabilities, and well-known brands, GM is accelerating its push into electric vehicles, software-defined platforms, and autonomous systems, while continuing to generate cash from its internal-combustion portfolio.
Air Products and Chemicals, Inc. (APD) entered the spotlight after announcing advanced discussions with Yara International on December 8 to collaborate on low-emission ammonia projects. While the strategic direction aligns with global decarbonization trends, uncertainty around execution and capital requirements triggered a 9.45% one-day decline in the stock.
APO shares have traded in a relatively tight range recently, consolidating near the $148 level. The stock reflects investor confidence in Apollo’s expanding asset base, record fee earnings, and disciplined execution amid renewed interest in alternative assets. Growth in retirement services through Athene continues to provide stability, helping offset volatility across private equity and credit markets.
Lockheed Martin and RTX Corporation are two of the most prominent names in the aerospace and defense industry, both positioned to benefit from heightened global security concerns and sustained U.S. military spending.
Eli Lilly and Novo Nordisk are among the most influential pharmaceutical companies in the rapidly expanding GLP-1 receptor agonist market, which targets diabetes and obesity. As competition intensifies and regulatory and pricing dynamics evolve, the divergence in their stock performance has become increasingly pronounced.
Lumentum and Ciena are leading players in the optical networking sector, positioned to capitalize on surging demand for high-speed data transmission driven by AI, cloud computing, and 5G rollouts. Their business models, however, diverge significantly: LITE focuses on specialized photonic components, while CIEN offers broader networking solutions.
As 2025 winds down, the Savings Banks sector reflects a mix of stability, innovation, and AI-driven disruption. Among the most closely watched tickers—SOFI Technologies (SOFI), Ally Financial (ALLY), and PayPal Holdings (PYPL)—investors have witnessed contrasting stories of growth, valuation, and market perception.
As 2025 comes to a close, financial markets remain dynamic, with technology and entertainment stocks capturing investor attention. Streaming platforms, in particular, are navigating content consolidation, evolving consumer preferences, and digital monetization shifts. Netflix (NFLX), Disney (DIS), and Spotify (SPOT) stand out as major players at the intersection of streaming, entertainment, and technology.
Ondas Holdings (ONDS) is a wireless technology company focused on delivering secure, long-range communications for industrial Internet of Things (IoT) and data networking applications. Its solutions are built to support mission-critical operations across sectors such as rail, energy, maritime, infrastructure, and industrial automation.
Ciena’s growth is driven by expanding offerings in optical networking, network automation software, and 5G transport infrastructure, complemented by services designed to help customers modernize and future-proof their networks. Its evolving technology portfolio addresses the rising complexity, speed, and reliability requirements of today’s communications environment.
Marathon Digital Holdings (MARA) and Riot Platforms (RIOT) are two leading companies in the Bitcoin mining industry, each operating energy-intensive infrastructure to capitalize on cryptocurrency market cycles. This comparison is especially relevant amid ongoing Bitcoin price volatility and growing interest in digital assets and AI-related infrastructure.
Roivant Sciences has delivered strong year-to-date performance, with shares up roughly 82%, driven by encouraging pipeline developments and increased investment in high-potential subsidiaries such as Immunovant.
MP Materials Corp. (MP) and USA Rare Earth, Inc. (USAR) are central to the United States’ push to establish a secure, domestic supply of rare earth elements—materials critical to electric vehicles, renewable energy, and defense technologies. As geopolitical tensions and supply chain vulnerabilities intensify, these two companies offer distinct approaches to addressing U.S. dependence on foreign sources.
SanDisk (SNDK) Corporation has emerged as one of the strongest performers in the semiconductor storage space, benefiting from its central role in AI infrastructure buildouts. The stock has risen more than fivefold from recent cycle lows, fueled by accelerating demand for high-capacity NAND flash and solid-state drives essential for data-intensive workloads.
As markets move into 2026, the outlook for SPY remains cautiously optimistic. Technical momentum, investor sentiment, and AI-driven forecasts align in favor of continued upside, assuming macroeconomic conditions remain stable and Federal Reserve policy evolves as expected.
Over the past year, the Direxion Daily Semiconductor Bull 3X Shares ETF (SOXL) has stood out as one of the market’s most volatile—and potentially rewarding—leveraged ETFs. Designed to deliver three times the daily performance of the ICE Semiconductor Index, SOXL closely tracks the heartbeat of the semiconductor industry, a sector at the core of global digital and AI transformation.